These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33441761)

  • 1. Differential effects on human cytochromes P450 by CRISPR/Cas9-induced genetic knockout of cytochrome P450 reductase and cytochrome b5 in HepaRG cells.
    Heintze T; Klein K; Hofmann U; Zanger UM
    Sci Rep; 2021 Jan; 11(1):1000. PubMed ID: 33441761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of hepatic cytochrome b
    Reed L; Indra R; Mrizova I; Moserova M; Schmeiser HH; Wolf CR; Henderson CJ; Stiborova M; Phillips DH; Arlt VM
    Toxicol Appl Pharmacol; 2019 Mar; 366():64-74. PubMed ID: 30685480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
    Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
    Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of cytochrome P450 oxidoreductase enhances metabolism and DNA adduct formation of benzo[a]pyrene in Hepa1c1c7 cells.
    Reed L; Jarvis IWH; Phillips DH; Arlt VM
    Mutagenesis; 2019 Dec; 34(5-6):413-420. PubMed ID: 31612222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that cytochrome b5 and cytochrome b5 reductase can act as sole electron donors to the hepatic cytochrome P450 system.
    Henderson CJ; McLaughlin LA; Wolf CR
    Mol Pharmacol; 2013 Jun; 83(6):1209-17. PubMed ID: 23530090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells.
    Ogasawara A; Kato N; Torimoto N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
    Drug Metab Lett; 2018; 12(1):14-23. PubMed ID: 29357810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Diminished NADPH:cytochrome P450 Reductase in Human Hepatocytes on Lipid and Bile Acid Homeostasis.
    Heintze T; Wilhelm D; Schmidlin T; Hofmann U; Zanger UM; Schwab M; Klein K
    Front Pharmacol; 2021; 12():769703. PubMed ID: 34867397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterologous expression of high-activity cytochrome P450 in mammalian cells.
    Kumondai M; Hishinuma E; Gutiérrez Rico EM; Ito A; Nakanishi Y; Saigusa D; Hirasawa N; Hiratsuka M
    Sci Rep; 2020 Aug; 10(1):14193. PubMed ID: 32843676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of approach to predict the contribution of multiple cytochrome P450s in drug metabolism using relative activity factor: effects of the differences in expression levels of NADPH-cytochrome P450 reductase and cytochrome b(5) in the expression system and the differences in the marker activities.
    Nakajima M; Tane K; Nakamura S; Shimada N; Yamazaki H; Yokoi T
    J Pharm Sci; 2002 Apr; 91(4):952-63. PubMed ID: 11948533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P450 redox enzymes in the white rot fungus Phanerochaete chrysosporium: gene transcription, heterologous expression, and activity analysis on the purified proteins.
    Subramanian V; Doddapaneni H; Syed K; Yadav JS
    Curr Microbiol; 2010 Oct; 61(4):306-14. PubMed ID: 20221604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies.
    Schulz C; Kammerer S; Küpper JH
    Clin Hemorheol Microcirc; 2019; 73(1):249-260. PubMed ID: 31561354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of yeast-expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5.
    Peyronneau MA; Renaud JP; Truan G; Urban P; Pompon D; Mansuy D
    Eur J Biochem; 1992 Jul; 207(1):109-16. PubMed ID: 1628642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced DNA adduct formation by benzo[a]pyrene in human liver cells lacking cytochrome P450 oxidoreductase.
    Reed L; Jarvis IWH; Phillips DH; Arlt VM
    Mutat Res Genet Toxicol Environ Mutagen; 2020 Apr; 852():503162. PubMed ID: 32265041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodiversity of the P450 catalytic cycle: yeast cytochrome b5/NADH cytochrome b5 reductase complex efficiently drives the entire sterol 14-demethylation (CYP51) reaction.
    Lamb DC; Kelly DE; Manning NJ; Kaderbhai MA; Kelly SL
    FEBS Lett; 1999 Dec; 462(3):283-8. PubMed ID: 10622712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of specifically active recombinant fused enzymes consisting of CYP3A4, NADPH-cytochrome P450 oxidoreductase, and cytochrome b5.
    Inui H; Maeda A; Ohkawa H
    Biochemistry; 2007 Sep; 46(35):10213-21. PubMed ID: 17691855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 enzymes but not NADPH oxidases are the source of the NADPH-dependent lucigenin chemiluminescence in membrane assays.
    Rezende F; Prior KK; Löwe O; Wittig I; Strecker V; Moll F; Helfinger V; Schnütgen F; Kurrle N; Wempe F; Walter M; Zukunft S; Luck B; Fleming I; Weissmann N; Brandes RP; Schröder K
    Free Radic Biol Med; 2017 Jan; 102():57-66. PubMed ID: 27863990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic effects of the flavonoids quercetin and naringenin on the metabolic activation of 2-amino-3,5-dimethylimidazo[4,5-f]quinoline by Salmonella typhimurium TA1538 co-expressing human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and cytochrome b5.
    Kang IH; Kim HJ; Oh H; Park YI; Dong MS
    Mutat Res; 2004 Jan; 545(1-2):37-47. PubMed ID: 14698415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-interference approach to study functions of NADPH : cytochrome P450 oxidoreductase in human hepatocytes.
    Feidt DM; Klein K; Nüssler A; Zanger UM
    Chem Biodivers; 2009 Nov; 6(11):2084-91. PubMed ID: 19937842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5.
    Kaspera R; Naraharisetti SB; Evangelista EA; Marciante KD; Psaty BM; Totah RA
    Biochem Pharmacol; 2011 Sep; 82(6):681-91. PubMed ID: 21726541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast.
    Hayashi K; Sakaki T; Kominami S; Inouye K; Yabusaki Y
    Arch Biochem Biophys; 2000 Sep; 381(1):164-70. PubMed ID: 11019832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.